HR 5074
118th Congress
House
Health
Digestive and metabolic diseases
Health care costs and insurance
Medicare
Prescription drugs
Kidney PATIENT Act of 2023
Introduced: July 28, 2023
Introduced by:
Carter, Earl L. "Buddy"
Republican
· Georgia
See on congress.gov
Everywhere this bill has been
10 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 11, 2024
Reported (Amended) by the Committee on Ways and Means. H. Rept. 118-548, Part I.
Mar 20, 2024
Ordered to be Reported (Amended) by the Yeas and Nays: 37 - 10.
Mar 20, 2024
Committee Consideration and Mark-up Session Held
Mar 12, 2024
Forwarded by Subcommittee to Full Committee by the Yeas and Nays: 16 - 10.
Mar 12, 2024
Subcommittee Consideration and Mark-up Session Held
Mar 6, 2024
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 41 - 1.
Mar 6, 2024
Committee Consideration and Mark-up Session Held
Aug 4, 2023
Referred to the Subcommittee on Health.
Jul 28, 2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 28, 2023
Introduced in House
Plain-English summary
Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments Act of 2023 or the Kidney PATIENT Act of 2023
This bill delays a change to the payment methodology under Medicare for oral drugs that are used to treat end-stage renal disease (ESRD).
Under current regulations, beginning January 1, 2025, the Centers for Medicare & Medicaid Services will incorporate payments for oral-only ESRD drugs into the ESRD prospective payment system rather than issuing separate payments to ESRD facilities. The bill delays implementation of this policy until January 1, 2033, or until an approved intravenous drug is available, whichever is earlier.
What's happening now
Reported (Amended) by the Committee on Ways and Means. H. Rept. 118-548, Part I.
Committees of jurisdiction
3